1993
DOI: 10.1007/bf03009729
|View full text |Cite
|
Sign up to set email alerts
|

Amrinone, in combination with norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

1994
1994
2011
2011

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 44 publications
(10 citation statements)
references
References 28 publications
1
9
0
Order By: Relevance
“…Patients were included if they experienced difficult weaning from bypass and required vasoactive medications to leave the operating room. Difficult separation from bypass was defined as a systolic blood pressure Ͻ80 mm Hg confirmed with central measurement (femoral or aortic), diastolic pulmonary artery pressure, or pulmonary artery capillary wedge pressure Ͼ15 mm Hg during progressive weaning from cardiopulmonary bypass and the use of inotropic or vasopressive support (norepinephrine Ͼ4 g/min, epinephrine Ͼ2g/min, dobutamine Ͼ2 g/kg/min, milrinone, or amrinone) or mechanical support (5,9,10).…”
Section: Methodsmentioning
confidence: 99%
“…Patients were included if they experienced difficult weaning from bypass and required vasoactive medications to leave the operating room. Difficult separation from bypass was defined as a systolic blood pressure Ͻ80 mm Hg confirmed with central measurement (femoral or aortic), diastolic pulmonary artery pressure, or pulmonary artery capillary wedge pressure Ͼ15 mm Hg during progressive weaning from cardiopulmonary bypass and the use of inotropic or vasopressive support (norepinephrine Ͼ4 g/min, epinephrine Ͼ2g/min, dobutamine Ͼ2 g/kg/min, milrinone, or amrinone) or mechanical support (5,9,10).…”
Section: Methodsmentioning
confidence: 99%
“…[6][7][8][9][10][11][12][13] In addition, milrinone has been shown to improve diastolic performance in patients with congestive heart failure.…”
Section: Méthode : Cinquante Patients Subissant Un Pac Ont éTé Randommentioning
confidence: 99%
“…In patients with heart failure, 9,10 the combination of milrinone and dobutamine causes an increase in HR and a fall in PCWP and SVR, which is consistent with our results. During weaning from cardiopulmonary bypass, 11 amrinone combined with norepinephrine maintains an adequate blood pressure. Because a higher dose of dopamine induces vasoconstriction through activating vascular α 1 -adrenergic receptors, 13 it is not unexpected that compared with two afterload reducers given simultaneously (milrinone + dobutamine), the combination of an afterload reducer and enhancer (milrinone and dopamine particularly in α-range) may work better, because of an unacceptable low blood pressure with the former combination.…”
Section: Discussionmentioning
confidence: 99%